🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a phase I, open-label, dose escalation trial to determine the...
Status
Completed
Location
China Medical University Hospital
Start Date
2011-07-19
Trial ID
NCT01403974
Treatments Being Tested
The main objective of the trial is to assess the efficacy of xentuzumab in ...
Status
Completed
Location
Ironwood Cancer and Research Centers
Start Date
2018-11-28
Trial ID
NCT03659136
Treatments Being Tested
This is a study in adult patients with different types of cancer. The purpo...
Status
Completed
Location
University of California Los Angeles
Start Date
2017-05-04
Trial ID
NCT03099174
Treatments Being Tested
The WINGMEN trial aims to understand how a hormone-like protein called insu...
Status
Completed
Location
Churchill Hospital, Oxford University Hospitals
Start Date
2021-12-17
Trial ID
NCT05110495
Treatments Being Tested
Phase Ib / II study to determine the Maximum Tolerated Dose and Recommended...
Status
Completed
Location
Medical University of Graz State Hospital - University Hospital Graz
Start Date
2014-05-15
Trial ID
NCT02123823
Treatments Being Tested
This study is a phase I, open-label, dose escalation trial to determine the...
Status
Completed
Location
St James's University Hospital
Start Date
2011-04-13
Trial ID
NCT01317420
Treatments Being Tested
Part A: To determine the maximum tolerated dose (MTD) and/or recommended ph...
Status
Completed
Location
National Hospital Organization Kyushu Cancer Center
Start Date
2014-10-21
Trial ID
NCT02191891
Treatments Being Tested
This open-label dose escalation phase I trial, 1280.15, is with the first a...
Status
Completed
Location
National Cancer Center Hospital East
Start Date
2014-06-11
Trial ID
NCT02145741
Treatments Being Tested
The overall aim of the trial is to investigate the safety and anti-tumour a...
Status
Completed
Location
Karmanos Cancer Institute
Start Date
2014-11-11
Trial ID
NCT02204072
Treatments Being Tested